What's the "hyper" in hyperacute stroke? Strategies to improve outcomes in ischemic stroke patients presenting within 6 hours

AACN Advanced Critical Care

Volumn 17, Issue 2, 2006, Pages 194-214

  Bader, Mary Kay ^a,b   Palmer, Sylvain ^a  

^a MISSION HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Hyperacute; Recombinant plasminogen activator; rtPA; Stroke

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACCREDITATION; ACUTE DISEASE; AGED; ALGORITHM; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DECISION TREE; EMERGENCY TREATMENT; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; INTENSIVE CARE; MALE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; REVIEW; STANDARD; TIME; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; AGED; ALGORITHMS; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOLS; CRITICAL CARE; DECISION TREES; EMERGENCY TREATMENT; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HUMANS; JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS; MALE; PRACTICE GUIDELINES; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 33745889601     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.1097/01256961-200604000-00016     Document Type: Conference Paper

References (78)

1. Williams G, Jiang J, Matchar D, Samsa G. Incidence and occurrence of total (first ever and recurrent) stroke. Stroke. 1999;30:2523-2538.
2. Broderick JP, Brott TG, Kothari R, Miller R, Khoury J, Pancioli A, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
3. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer J, Jacobson MF. Lifetime cost of stroke in the US. Stroke. 1996;27:1459-1466.
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
5. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both or neither among 19,435 patients with acute ischemic stroke. Lancet. 1997;349:1569-1581.
6. Chinese Acute Stroke Trial (CAST) Collaboration. Collaborative overview of randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet. 1997;349:1641-1649.
7. Albers G, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2001;119(Suppl):300S-320S.
8. Morley NC, Berge E, Cruz-Flores S, Whittle IR. Surgical decompression for cerebral oedema in acute ischemic stroke. Cochrane Database Syst Rev. 2002;CD003435.
9. Cowan JA, Dimick JB, Wainess RM, Upchurch GF, and Thompson BG. Outcomes after cerebral aneurysm clip occlusion in the United States: the need for evidence-based hospital referral. J Neurosurg. 2003;99:947-952.
10. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635-640.
11. Jorgensen HS, Nakayama H, Rasschou HO, Larsen K, Hubbe P, and Olsen TS. The effect of a stroke unit: reductions in mortality, discharge rate to nursing home, length of hospital stay and cost. Stroke. 1995;26:1178-1182.
12. Alberts ML, Hademenos G, Latchaw R, Jagoda A, Marler JR, Mayberg MR et al. Recommendations for the Establishment of Primary Stroke Centers. JAMA. 2000;283:3102-3109.
13. Alberts ML, Latchaw R, Selman W, Shephard T, Hadley MN, Brass LM, et al. Recommendations for Comprehensive Stroke Centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36:1597-1618.
14. Schwamm LH, Pancioli A, Acker JE, Goldstein LB, Zorowitz RD, Shephard TJ, et al. recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Associations Task Force on the Development of Stroke Systems. Circulation. 2005;111:1078-1091.
15. JCAHO. Primary stroke center certification. Available at: http://www.jcaho.org/dscc/psc/. Accessed October 12, 2005.
16. JCAHO. Primary stroke centers, standardized stroke measure set. Available at: http://www.jcaho.org/dscc/psc/stroke+measure+set.htm. Accessed October 12, 2005.
17. Sharmer M, Clark H, Armour T, Stotts C, Cote R, Hill MD, Demchuck AM, et al. Evidence Report/Technology Assessment Number 127: Acute Stroke Evaluation and Treatment [AHRQ Pub No. 05-E023-1; ISSN 1530-440X]. Rockville, MD: Agency for Healthcare Research and Quality, July 2005.
18. Hill MD, Barber PA, Demchuck AM, et al. Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke. Can Med Assoc J. 2000;162(11):1589-1593.
19. Lattimore S, Chalele J, Davis L, DeGraba T, Ezzeddine M, Haymore J, et al. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital stroke center experience. Stroke. 2003;34:e55-e57.
20. Petty G, Brown R, Whisnaunt J, Sicks J, O'Fallon W, and Wiebers D. Ischemic stroke subtypes: a population based study of incidence and risk factors. Stroke. 1999;30:2513-2516.
21. Schneider A, Kissela B, Woo D, Kleindorfer D, Alwell K, Miller R, et al. ischemic stroke subtypes: a population based study of incidence rates among blacks and whites. Stroke. 2004;35:1552-1556.
22. Baumgartner R, Sidler C, Mosso M, Georgiadis D. Ischemic lacunar stroke in patients with and without potential mechanism other than small-artery disease. Stroke. 2003;34:653-659.
23. Lindsbert P. Brain tissue salvage in acute stroke. Neurocrit Care. 2004;1:301-308.
24. Semplicini A, Maresca A, Boscolo G, Sartori M, Rocchi R, Giantin V, et al. Hypertension in acute ischemic stroke. Arch Intern Med. 2003;163:211-216.
25. Adams H, Adams R, Brott T, del Zoppo G, Furlan A, Goldstein L, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-1083.
26. Hinkle J, Guanci M, Bowman L, Hermann L, McGinty L, and Rose J. Cerebrovascular events in the nervous system. In Bader MK, Littlejohns LJ, eds. AANN Core Curriculum for Neuroscience Nursing, 4th ed. St. Louis, MO: Elsevier Health Sciences, 2004; 536-585.
27. Bhalla A, Wolfe C, Rudd A. Management of acute physiological parameters after stroke. Q J Med. 2001;94:167-172.
28. Adams H, Adams R, Del Zoppo G, Goldsstein L. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update. Stroke. 2005;36:916-921.
29. Rose J, Mayer S. Optimizing blood pressure in neurological emergencies. Neurocrit Care. 2004;1:287-299.
30. Castillo J, Leira R, Garcia M, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke. 2004;35:520-527.
31. Vlcek M, Schillinger M, Lang W, Lalouschek W, Bur A, Hirschl M. Association between course of blood pressure within first 24 hours and functional recovery after acute ischemic stroke. Ann Emerg Med. 2003;42:619-626.
32. Leonardi-Bee J, Bath P, Phillips S, Sandercock P. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33:1315-1320.
33. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet. 1997;349:1569-1581.
34. Willmot M, Leonarid-Bee J, Bath P. High blood pressure in acute stroke and subsequent outcomes: a systematic review. Hypertension. 2004;43:18-24.
35. Goldstein L. Blood pressure management in patients with acute ischemic stroke. Hypertension. 2004;43: 137-141.
36. Cape SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in non-diabetic and diabetic patients: a systematic review. Stroke. 2001;32:2426-2432.
37. Baird T, Parsons M, Phanh T, Butcher K, Desmond P, Tress B, et al. Persistent post stroke hyperglycemia is independently associated with infarct expansion and worse clinical outcomes. Stroke. 2003;34:2208-2214.
38. Williams L, Rotich J, Fineber N, Espay A, Bruno A., Fineberg S, Tierney W. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67-71.
39. Alvarez-Sabin J, Molina C, Ribo M, Arnillas J, Montaner J, Huertas R, et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke. 2004;35:2493-2499.
40. Bruno A, Levine SR, Frankel MR, Brott T, Lin Y, Tilley BC, Lyden P, Broderick J, Kwiatkowski T, Fineberg S. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology. 2002;59:669-674.
41. Tanne D, Kasner S, Demchuk A, Koren-Morag N, Hanson S, Grond M, Levine S. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rt-PA Stroke Survey. Circulation. 2002;105:1679-1685.
42. Lindsberg P, Roine R. Hyperglycemia in acute stroke. Stroke. 2004;35:363-364.
43. Reith J, Jorgensen H, Pederson P, Nakayama H, Raaschou H, Jeppersen L, Olsen T. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality and outcome. Lancet. 1996;347:422-425.
44. Wang Y, Lim L, Levi C, Heller R, Fisher J. Influence of admission body temperature on stroke mortality. Stroke. 2000;31:404-409.
45. Kammersgaard L, Jorgensen H, Rungby J, Reith J, Nakayama H, Weber U, et al. Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke. 2002;33:1759-1762.
46. Lyden P, Allgren R, Ng K, Akins P, Meyer B, Al-Sanani F, et al. Intravascular cooling in the treatment of stroke (ICTuS): early clinical experience. J Stroke Cerebrovasc Dis. 2005;14:107-114.
47. Ramsey D, Smithard D, Kalra L. Early assessment of Dysphagia and aspiration risk in acute stroke patients. Stroke. 2003;34:1252-1257.
48. Wojner-Alexandrov AW, Alexandrov A, Rodriguez D, Persse D, Grotta J. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke. 2005;36:1512-1518.
49. Korthari RU, Pancioli A, Liu T, Brott J, Broderick J. Cincinnati pre-hospital stroke scale: reproducibility and validity. Ann Emerg Med. 1999;33:373-378.
50. Center for Research in Medical Education. Miami Emergency Neurologic Deficit (MEND) Pre-Hospital Checklist. Miami, FL: University of Miami, 2001.
51. Whelley-Wilson C, Newman G. A stroke scale for emergency triage. J Stroke Cerebrovasc Dis. 2004;13: 247-253.
52. American Heart Association (AHA). Cummins R, ed. ACLS Provider Manual. Dallas, TX: AHA, 2001; 195.
53. Broderick J, Hacke W. Treatment of acute ischemic stroke - part I: recanalization strategies. Circulation. 2002;106:1563-1569.
54. Reed S, Cramer S, Blough D, Meyer K, Jarvik J. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;332:1832-1840.
55. Katzan IL, Furlan Aj, Lloyd LE, Frank JL, Harper DL, Hinchey JA, Hammel JJP, Qu A, and Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;83:1151-1158.
56. Grotta JC, Burgin WS, El-Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexandrov AV. Intravenous tissue plasminogen activator for acute ischemic stroke: Houston experience from 1996 to 2000. Arch Neurol. 2001;58:2009-2113.
57. The Paul Coverdell Prototype Registries Writing Group. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke. 2005;36:1232-1240.
58. Cocho D, Belvis R, Marti-Fabregas J, Molina-Porcel L, Diaz-Manera J, Aleu A, et al. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology. 2005;64:719-720.
59. O'Connor R, McGraw P, Edelsohn L. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med. 1999;33:9-14.
60. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from rt-PA therapy〉 an analysis of patient eligibility. Neurology. 2001;56:1015-1020.
61. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous rtPA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
62. Tanne D, Gorman M, Bates V, Kasner S, Scott P, Verro P, et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the rtPA stroke survey experience. Stroke. 2000;31:370-375.
63. Wang DZ, Rose JA, Honings Ds, Garwacki DJ, Milbrandt JC. Treating ischemic stroke patients with intravenous rt-PA: the OSF stroke network experience. Stroke. 2000;31:77-81.
64. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM: Cleveland clinic health system stroke quality improvement and tissue-type plasminogen activator for acute ischemic stroke: Cleveland update. Stroke. 2003;34:799-800.
65. Stroke Unit Trialists' Collaboration. Collaborative systemic review of the randomized trials of organized inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151-1159.
66. Rudd A, Hoffman A, Irwin P, Lowe D, Pearson M. Stroke unit care and outcome: results from the 2001 National Sentinel Audit of Stroke (England, Wales, and Northern Ireland). Stroke. 2005;36:103-106.
67. Glader E, Stegmayr B, Johansson L, Hulter-ASbert K, Wester P. Differences in long-term outcomes between patients treated in stroke units and in general wards: a 2 year follow-up of stroke patients in Sweden. Stroke. 2001;32:2124-2130.
68. Lewandowski C, Frankel M, Tomsick T, Broderick J, Frey J, Clark W, et al. Combined intravenous and intra-arterial r-RTPA versus intra-arterial therapy of acute ischemic stroke. Stroke. 1999;30:2598-2605.
69. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke. 2004;35:904-912.
70. Flaherty M, Woo D, Kissela B, Jauch E, Pancioli A, Carrozzella J et al. Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology. 2005;64:386-388.
71. Jovin T, Gebel J, Wechsler L. Intra-arterial thrombolysis for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2002;11:148-161.
72. Higashida R, Furlan A, for the Technology Assessment Committees of the American Society of Interventional and Therapeutic Neuroradiology and the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34:e109-e137.
73. Furlan A, Higashida R, Wechsler L, Gent M, Rowely H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: A randomized controlled trial. JAMA. 1999;282:2003-2011.
74. Smith W, Sung G, Starkman S, Saver J, Kidwell C, Gobin P, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI Trial. Stroke. 2005;36:1432-1440.
75. Concentric-Medical. Merci Retrieval System Comprehensive Review Presentation. Mountain View, CA: Concentric Medical, 2005.
76. Becker K, Brott T. Approval of the MERCI clot retriever: a critical review. Stroke. 2005;36:400-403.
77. Leary M, Saver J, Gobin YP, Jaha R, Duckwiler G, Vinuela F, et al. Beyond tissue plasminogen activator: mechanical intervention in acute stroke. Ann Emerg Med. 2003;41:838-846.
78. Nakano S, Wakisaka S. Mechanical recanalization for acute ischemic stroke. Neurocrit Care. 2004;1:379-3383.